2023-07-17 - LD Munich - Amgen v. Sanofi et al. - UPC_CFI_14/2023
- Aktenzeichen:
- UPC_CFI_14/2023
- Datum:
- Spruchkörper:
- Court of First Instance - Munich (DE) Local Division
- Art:
- Order
- Parteien:
- Amgen Inc. v. Sanofi-Aventis Deutschland GmbH
Kernaussage: The Munich Local Division, by order of the judge-rapporteur, separated the infringement proceedings against Regeneron (Defendant 4) from those against the Sanofi defendants (1-3) under Rule 303.
2023-07-17 - LD Munich - Amgen
v.
Sanofi et al. - UPC_CFI_14/2023
routine
The Munich Local Division, by order of the judge-rapporteur, separated the infringement proceedings against Regeneron (Defendant 4) from those against the Sanofi defendants (1-3) under Rule 303.2 RoP because e-mail service could not be effected on Regeneron, while the Sanofi defendants had accepted e-mail service on 11 July 2023. The court held that waiting for successful physical service on Regeneron (now required under Rule 274.1(a)(ii) RoP) would delay the Sanofi branch of the case by months, justifying separation to preserve the procedural calendar. The court fee already paid was ordered to be split equally between the two resulting proceedings in application of Rule 303.3 RoP. The court also clarified that the Rule 337 RoP requirement to hear parties before such a decision extends only to those parties already represented by counsel with CMS access.
Inoffiziell
Inoffizielle KI-Übersetzung
Dies ist eine automatische, von KI erstellte Übersetzung, die Fehler enthalten kann. Rechtsverbindlich ist allein das Originaldokument in der Verfahrenssprache (German).